Rahul Jasuja


FBR Reiterates Buy On Arena Pharmaceuticals, Inc. (ARNA) Following 4Q16 Update

In a research report published Wednesday, FBR analyst Rahul Jasuja reiterated an Outperform rating on shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) with a …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts